Improving coronary artery outcomes for children with Kawasaki disease

Lancet. 2019 Mar 16;393(10176):1077-1078. doi: 10.1016/S0140-6736(18)33133-7. Epub 2019 Mar 7.

Authors

Brian W McCrindle¹, Anne H Rowley²

Affiliations

¹ Department of Pediatrics, University of Toronto, Labatt Family Heart Centre, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada. Electronic address: brian.mccrindle@sickkids.ca.
² Department of Pediatrics, Northwestern University Feinberg School of Medicine, The Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

PMID: 30853152
DOI: 10.1016/S0140-6736(18)33133-7

No abstract available

Publication types

Comment

MeSH terms

Child
Coronary Artery Disease*
Cyclosporine
Humans
Immunoglobulins, Intravenous
Mucocutaneous Lymph Node Syndrome*

Substances

Immunoglobulins, Intravenous
Cyclosporine